Literature DB >> 5786936

Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer.

H R Colten, T Borsos, H J Rapp.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5786936     DOI： 10.1016/0019-2791(69)90302-4

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  8 in total

1.  Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.

Authors:  R Hällgren
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

2.  The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten.

Authors:  N E Hyslop; R R Dourmashkin; N M Green; R R Porter
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

3.  Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin.

Authors:  M M Frank; T Gaither
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

4.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

6.  A case of Menetrier's disease associated with protein-losing gastropathy and abnormal serum complement profile.

Authors:  M Kondo; H Nishibori; M Ikezaki; S Takemura; M Masuda
Journal:  Gastroenterol Jpn       Date:  1978

7.  Demonstration and quantitation of activation of the first component of complement in human serum.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

8.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.